Biotech business: funding opportunities презентация

Июнь 18, 2021

Главная
Бизнес
Biotech business: funding opportunities

Содержание

2. PRODUCT DEVELOPMENT CYCLE FOR A DRUG
3. BIOTECHNOLOGY BUSINESS: Time to recover R&D costs are being compressed
4. THE VALUE OF THE BIOTECH COMPANY’S ASSET varies with market and geographic region
5. THE SAN FRANCISCO BAY AREA a major biotechnology claster
6. THE BOSTON/CAMBRIDGE a world-top biotechnology claster
7. BioBAT AT BROOKLING ARMY TERMINAL a biotechnology incubator
8. SILICON VALLEY
9. MEDICON VALLEY
10. Abundance of high quality, adequately funded academic research Ready resource of seasoned and experienced biotechnology entrepreneurs
11. WORLD’S 2012 R&D SPENDING
12. CAPITAL RAISED IN 2012 USA vs Europe
13. BEST STARTUP FUNDING COUNTRIES IN EUROPE Gruber 2009
14. STARTUP FUNDING SOURCES Personal capital (Fools), Friends and Family (FFF) Government grants and financing programs Angel
15. STARTUP FUNDING SOURCES
16. PERSONAL CAPITAL ~5-20% of the company assets relatively small, varies: 500 USD (Rob Swanson + Herb
17. FFF relatively small, varies, up to tens of thousands USD, sometimes up to hundreds of thousands
18. GOVERNMENT GRANTS AND FINANCING PROGRAMS relatively large (up to several millions USD), non-dilutive hard to get
19. https://www.sbir.gov/ https://www.helmholtz.de/transfer/technologietransfer/transferinstrumente/helmholtz_enterprise/ GOVERNMENT GRANTS AND FINANCING PROGRAMS
20. ANGEL INVESTORS USD 20-250 K, relatively easy to get
21. VENTURE CAPITAL INVESMENTS Large, highly professional management, high-diluting
22. CORPORATE PARTNERSHIP
23. IPO, ACQUISITIONS, SELLS
25. Скачать презентацию

Слайд 2

PRODUCT DEVELOPMENT CYCLE FOR A DRUG

Слайд 3

BIOTECHNOLOGY BUSINESS:
Time to recover R&D costs are being compressed

Слайд 4

THE VALUE OF THE BIOTECH COMPANY’S ASSET
varies with market and geographic region

Слайд 5

THE SAN FRANCISCO BAY AREA
a major biotechnology claster

Слайд 6

THE BOSTON/CAMBRIDGE
a world-top biotechnology claster

Слайд 7

BioBAT AT BROOKLING ARMY TERMINAL
a biotechnology incubator

Слайд 8

SILICON VALLEY

Слайд 9

MEDICON VALLEY

Слайд 10

Abundance of high quality, adequately funded academic research
Ready resource of seasoned and experienced

biotechnology
entrepreneurs

Ready access to sources of at-risk, early and development-stage capital willing to fund start-up concepts

Adequate supply of technically skilled workforce experienced in the biotechnology industry

Availability of dedicated wet-laboratory and specialized
facilities at affordable rates

WHAT IS A BIOTECH CLUSTER?

Слайд 11

WORLD’S 2012 R&D SPENDING

Слайд 12

CAPITAL RAISED IN 2012
USA vs Europe

Слайд 13

BEST STARTUP FUNDING COUNTRIES IN EUROPE
Gruber 2009

Слайд 14

STARTUP FUNDING SOURCES
Personal capital
(Fools), Friends and Family (FFF)
Government grants and financing programs
Angel investors
Foundation

with the focus in you sectors

Venture capital industry

Institution corporate partnership

Institutional debt financing

Слайд 15

STARTUP FUNDING SOURCES

Слайд 16

PERSONAL CAPITAL
~5-20% of the company assets
relatively small, varies:
500 USD (Rob Swanson

+ Herb Boyer in Genentech)
tens of thousands USD

Слайд 17

FFF
relatively small, varies,
up to tens of thousands USD, sometimes up to hundreds of

thousands USD

Слайд 18

GOVERNMENT GRANTS AND FINANCING PROGRAMS
relatively large (up to several millions USD), non-dilutive
hard to

get

https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/index.html

Слайд 19

https://www.sbir.gov/
https://www.helmholtz.de/transfer/technologietransfer/transferinstrumente/helmholtz_enterprise/
GOVERNMENT GRANTS AND FINANCING PROGRAMS

Слайд 20

ANGEL INVESTORS
USD 20-250 K, relatively easy to get

Слайд 21

VENTURE CAPITAL INVESMENTS
Large, highly professional management, high-diluting

Слайд 22

CORPORATE PARTNERSHIP

Слайд 23

IPO, ACQUISITIONS, SELLS